Mapping the human mucosal immune response to respiratory viruses
Mapping the human mucosal immune response
to respiratory viruses
Conventionally, human immune responses have been extensively characterized using blood. Immune cells, though abundant in blood, are also found in various tissues in varying numbers and with locally relevant functional specification. Assessing immune responses in the airways over the course of infection and convalescence is critical to comprehensively mapping immunity to respiratory viral infections including influenza and SARS-CoV-2.
In a study recently published in eLife, Sindhu Vangeti, PhD, and colleagues at the Icahn School of Medicine at Mount Sinai, demonstrated that innate immune cells, like monocytes and dendritic cells, possess unique dynamics defined by location and pathogen. In addition to characterizing immune cells in blood, the team also investigated immune cell distribution and function in the human nasopharynx.
Learn about:
- Monocytes and dendritic cells in human respiratory viral infections.
- Studying immune responses in the human airways.
- Integrating state-of-the-art platforms into conventional study design.
Sindhu Vangeti, PhD
Sindhu Vangeti, PhD, is a postdoctoral fellow in Irene Ramos’s viral immunology team in the Stuart C. Sealfon lab at the Icahn School of Medicine at Mount Sinai. Currently, her research focuses on mapping the epigenetic fingerprint of influenza/SARS-CoV-2 exposure and studying mechanisms that lead to durability of vaccine-induced immunity. Dr. Vangeti obtained her doctorate in 2019 at the Karolinska Institutet in the lab of Anna Smed Sörensen, studying human immune responses to influenza and hantavirus infections.
Mapping the human mucosal immune response to respiratory viruses
A presentation by Sindhu Vangeti, PhD
More resources for immunology research
What can proteomics teach us about infectious disease?
Tech Note:
SomaScan Assay v4.1 signaling in mouse plasma
Case studies:
Massive-scale proteomics for COVID-19
White paper:
COVID-19 and the SomaScan® Platform
Search our publications viewer
Search our extensive database of peer-reviewed research on the use of the SomaScan® Platform by entering keywords to narrow your search, such as influenza, COVID, or respiratory.
More webinars
WebinarEvaluation of precision and correlation for the latest proteomic platforms
The field of proteomics is rapidly advancing, enabling precise measurement of thousands of proteins, particularly those in higher abundance. This webcast will explore significant differences in precision within and across the latest large-scale proteomic platforms and their intercorrelations, based on blind duplicate split assays of the leading modified aptamer-based 11K and antibody proximity ligation-based 5K platforms. Each platform exhibits distinct strengths and limitations, requiring careful consideration prior to implementation in individual studies.
WebinarScaling Proteomics: Balancing Performance and Measuring Enough Proteins
As proteomics platforms have advanced, the number of proteins measured and sample throughput have dramatically increased. However, have sacrifices or trade-offs been necessary to make these gains? To find out, Stephen Williams will analyze how the performance of proteomics platforms has changed over time, comparing precision, sensitivity and specificity as throughput increases.
WebinarFrom discovery to clinical insights – the power of integrating proteomics and genomics data
The value of adding high-plex proteomics to existing genomics data and how proteogenomic approaches accelerate drug target discovery and repurposing. Watch this presentation given by Maik Pietzner, PhD, at ESHG 2024.